Specific Therapy of Olfactory Disorders in COVID-19 Patients is Essential for the Prevention of Long-term Dysfunction.
作者信息
Vaira Luigi Angelo, Lechien Jerome R, Dore Stefano, Boccaletti Riccardo, Saussez Sven, De Riu Giacomo
机构信息
Maxillofacial Surgery Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Viale San Pietro 10, 07100 Sassari, Italy.
Biomedical Science Department, PhD School of Biomedical Science, University of Sassari, Sassari, Italy.
出版信息
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3102-3103. doi: 10.1007/s12070-021-02818-z. Epub 2021 Aug 22.
Abstract
摘要
相似文献
1
Specific Therapy of Olfactory Disorders in COVID-19 Patients is Essential for the Prevention of Long-term Dysfunction.新冠患者嗅觉障碍的特异性治疗对预防长期功能障碍至关重要。
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3102-3103. doi: 10.1007/s12070-021-02818-z. Epub 2021 Aug 22.
2
Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell.口服皮质类固醇和嗅觉训练治疗 COVID-19 相关嗅觉丧失的疗效和安全性。
Eur Arch Otorhinolaryngol. 2021 Aug;278(8):3113-3117. doi: 10.1007/s00405-020-06520-8. Epub 2021 Jan 9.
3
Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered.嗅觉丧失：对其在 COVID-19 中的重要性的认识的演变，以及仍有待回答的问题。
Eur Arch Otorhinolaryngol. 2021 Jul;278(7):2187-2191. doi: 10.1007/s00405-020-06285-0. Epub 2020 Sep 9.
4
Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction.288 例新冠病毒病嗅觉障碍患者的临床系列中嗅觉恢复的预测因素。
Eur J Neurol. 2021 Nov;28(11):3702-3711. doi: 10.1111/ene.14994. Epub 2021 Jul 9.
5
Management of Anosmia in COVID-19: A Comprehensive Review.新冠病毒感染所致嗅觉丧失的管理：一项综合综述
Cureus. 2022 Oct 18;14(10):e30425. doi: 10.7759/cureus.30425. eCollection 2022 Oct.
6
A 32-Year-Old Man with Persistent Olfactory Dysfunction Following COVID-19 Whose Recovery Was Evaluated by Retronasal Olfactory Testing.一位 32 岁男性，感染新冠病毒后嗅觉持续丧失，经逆行嗅觉测试评估其恢复情况。
Am J Case Rep. 2022 Sep 12;23:e936496. doi: 10.12659/AJCR.936496.
7
Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19.COVID-19 患者嗅觉功能障碍的六个月心理物理学评估。
Chem Senses. 2021 Jan 1;46. doi: 10.1093/chemse/bjab006.
8
[The optimization in the rehabilitation of anosmia after SARS-CoV-2 infection].[新型冠状病毒感染后嗅觉丧失的康复优化]
Vestn Otorinolaringol. 2022;87(1):33-38. doi: 10.17116/otorino20228701133.
9
[Loss of smell, a preliminary indicator of COVID-19].[嗅觉丧失，新冠病毒病的一个初步指标]
Rev Med Inst Mex Seguro Soc. 2021 Feb 2;59(1):4-6. doi: 10.24875/RMIMSS.M21000046.
10
Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb.在已故的 COVID-19 患者中观察到，SARS-CoV-2 如何攻击呼吸道和嗅觉黏膜，但嗅觉球不受影响。
Cell. 2021 Nov 24;184(24):5932-5949.e15. doi: 10.1016/j.cell.2021.10.027. Epub 2021 Nov 3.
引用本文的文献
1
Post-Viral Olfactory Loss: What We Learned from the SARS-CoV-2 Pandemic.病毒感染后嗅觉丧失：我们从新冠疫情中学到的经验
Life (Basel). 2022 Nov 12;12(11):1868. doi: 10.3390/life12111868.
2
The prevalence of sensory changes in post-COVID syndrome: A systematic review and meta-analysis.新冠后综合征中感觉变化的患病率：一项系统评价和荟萃分析。
Front Med (Lausanne). 2022 Aug 25;9:980253. doi: 10.3389/fmed.2022.980253. eCollection 2022.
3
Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.预防持续性 COVID-19 后嗅觉功能障碍的干预措施。
Cochrane Database Syst Rev. 2022 Sep 5;9(9):CD013877. doi: 10.1002/14651858.CD013877.pub3.
4
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.治疗持续性 COVID-19 后嗅觉功能障碍的干预措施。
Cochrane Database Syst Rev. 2022 Sep 5;9(9):CD013876. doi: 10.1002/14651858.CD013876.pub3.
5
The Effects of Persistent Olfactory and Gustatory Dysfunctions on Quality of Life in Long-COVID-19 Patients.持续性嗅觉和味觉功能障碍对新冠长期患者生活质量的影响。
Life (Basel). 2022 Jan 19;12(2):141. doi: 10.3390/life12020141.
本文引用的文献
1
Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study.2019 冠状病毒病患者 6 个月的嗅觉和味觉恢复率：一项前瞻性心理物理学研究。
J Laryngol Otol. 2021 May;135(5):436-441. doi: 10.1017/S002221512100116X. Epub 2021 Apr 23.
2
Otorhinolaryngological Manifestations and Its Management in COVID 19 Patients.COVID-19患者的耳鼻喉科表现及其管理
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3391-3394. doi: 10.1007/s12070-021-02436-9. Epub 2021 Feb 17.
3
Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19.COVID-19 患者嗅觉功能障碍的六个月心理物理学评估。
Chem Senses. 2021 Jan 1;46. doi: 10.1093/chemse/bjab006.
4
Efficacy of corticosteroid therapy in the treatment of long- lasting olfactory disorders in COVID-19 patients.COVID-19 患者持续性嗅觉障碍的皮质类固醇治疗疗效。
Rhinology. 2021 Feb 1;59(1):21-25. doi: 10.4193/Rhin20.515.
5
Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia.长期 COVID-19 相关嗅觉丧失的嗅上皮组织病理学发现。
J Laryngol Otol. 2020 Dec;134(12):1123-1127. doi: 10.1017/S0022215120002455. Epub 2020 Nov 16.
Zotero 插件